|Bid||1.2200 x N/A|
|Ask||1.2400 x N/A|
|Day's range||1.2100 - 1.2500|
|52-week range||1.1700 - 3.1900|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Earnings date||21 Nov 2022 - 25 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2.45|
September is historically the worst month of the year for the S&P 500. Maybe it's time to think bigger by going smaller.
Aurora Cannabis, Canopy Growth, OrganiGram Holdings, and Tilray Brands are all in the red yet again today.
Penny stocks, or equities trading at under $5 a share, are typically a no-go area for most investors. Capital-intensive commercial operations in the areas of biotechnology, healthcare, and technology can force fledgling companies to rely heavily on public offerings to get off the ground. The silver lining to this story is that the small group of companies that actually use these early public offerings to build successful businesses often yield enormous returns for shareholders.